Maven Securities LTD Tempest Therapeutics, Inc. Put Options Transaction History
Maven Securities LTD
- $1.61 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TPST
# of Institutions
34Shares Held
1.43MCall Options Held
161KPut Options Held
78K-
Black Rock Inc. New York, NY508KShares$1.03 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$355,9090.0% of portfolio
-
Geode Capital Management, LLC Boston, MA132KShares$266,8070.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$261,7490.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX106KShares$213,3120.05% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $21M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...